Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer [Yahoo! Finance]
Assessing Arcellx (ACLX) Valuation After Strong Multi-Year Share Price Gains [Yahoo! Finance]
Gilead Sciences Details Tubulis, Ouro, Arcellx Deals as Pipeline Catalyst, 2026 Updates Loom [Yahoo! Finance]
Gilead to buy Ouro Medicines for up to $2.2 billion [Yahoo! Finance]
Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research [Yahoo! Finance]